Drug Shortage Report for POTASSIUM CHLORIDE INJECTION

Last updated on 2019-11-29 History
Report ID 98262
Drug Identification Number 02241679
Brand name POTASSIUM CHLORIDE INJECTION
Common or Proper name POTASSIUM CHLORIDE INJECTION
Company Name BAXTER CORPORATION
Market Status MARKETED
Active Ingredient(s) POTASSIUM CHLORIDE
Strength(s) 29.8MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS
Packaging size 50 mL (JB0822)
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-11-08
Actual start date 2019-11-08
Estimated end date 2019-11-28
Actual end date 2019-11-28
Shortage status Resolved
Updated date 2019-11-29
Company comments Consult local pharmacy to find clinical alternatives. Alternative concentrations/doses are available including 10 mmol Potassium Chloride in 50 mL Sterile Water for Injection (Code: JB0821P, DIN: 02241677).
Health Canada comments
Tier 3 Status No
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2019-11-29 English Compare
v5 2019-11-28 French Compare
v4 2019-11-28 English Compare
v3 2019-11-09 English Compare
v2 2019-11-08 French Compare
v1 2019-11-08 English Compare

Showing 1 to 6 of 6